Skip to content

Cancers & treatments

News & evidence

Living with cancer

Learn & contribute

Loading

A public, cited, editable map of oncology: technologies, targets, products, companies, institutions, pathways, trials, pairings, roadmaps, and ideas. One page per object, with a plain-language TL;DR on every page.

Work in progress. Every fact on this site is being built and checked in the open and may be incomplete, out of date, or wrong. You must do your own research and verify anything here at its primary source before relying on it. Nothing on this site is medical advice; decisions belong with you and your clinicians.

OnCo is an information resource, not medical advice. Nothing here replaces a conversation with a qualified clinician. Never delay care because of something you read here; in an emergency, call your local emergency services. Terms of use

Browse by cancer
Tags
Search
Connections
For me
Navigator
Biomarker matrix
Calculators
Interactions
Decision aids
Checkpoint side effects
Tumour board
Compare
Counts by category
Rankings
Timeline
Year by year
Query builder
Graph explorer
Saved
Body map

Cancers & treatments

News & evidence

Institutions & people

Institutions
Universities
Trial leadership
People
Heroes and heroines
Companies
Startups
Requests for startups
Investors
Company scorecards
Trial sponsors
Manufacturing map
Countries
United States deep dive
India deep dive
China deep dive
Germany deep dive
Israel deep dive
United Kingdom deep dive
Cases by country
Funding flows

Living with cancer

For me
The first 60 days
Appointment prep pack
Side effects
Symptom to test
Report reader
Survivorship planner
Second opinion
Financial help
Free in oncology
Paying for care in the US
NHS coverage
Paying for care in India
Coverage rankings
Cutting cancer care costs
Diet, exercise and lifestyle
Supportive care
Recovery and rejuvenation
Complementary and supportive approaches
Hair loss and regrowth
What comes back after treatment
Heroes and heroines

Learn & contribute

Reading paths
About & methodology
Roadmap
Gaps to fill
Coverage of the field
Review queue
Reviewer roster
Contributors
Idea votes
Teaching packs
Weekly issue
Suggest an edit
Answer quality
Data dictionary
Build on OnCo
Open API
Open data
Open tools
Open source in oncology
The software of oncology
GitHub

© 2026 OnCo. Code MIT. The data are free for individual and educational use with the attribution “Data from OnCo (onco.cc)”, under CC BY-NC 4.0. Commercial use must contact us to pay for the data. Commercial licences. Made with heart and soul by Jude Gomila .

About and methodology Corrections Open API Tags Terms of use Privacy policy GitHub

Loading

Home
Companies
intoDNA

companiesCompany

I

intoDNA

A Krakow spin-out from the Jagiellonian University whose STRIDE assay counts individual DNA breaks in cells, sold to drug developers and aimed at predicting who responds to DNA-repair drugs.

Also called: intoDNA S.A.

Overview Connected6

Overview

intoDNA was founded in 2016 by researchers from the Jagiellonian University in Krakow to commercialise STRIDE, a fluorescence method that detects single- and double-strand DNA breaks directly in fixed cells. The company offers STRIDE as a contract research service to pharmaceutical and biotech companies developing DNA damage response drugs, radiosensitisers and chemotherapy combinations, and is working towards a functional companion test for PARP inhibitor response.

Headquarters

Krakow, Poland, PL

Type

Stage

Startup

Website

Founded

2016

Connected

Similar pages

Technology
HRD genomic scar scores (GIS, LOH, HRDetect)
Shares STRIDE DNA break detection (intoDNA), RAD51 foci assay (functional HRD test), HRD & BRCA testing, Ovarian cancer.
Idea
A functional test for homologous recombination deficiency validated across laboratories
Shares HRD & BRCA testing, Ovarian cancer.
Key paper
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Shares HRD & BRCA testing, Breast cancer (all types).
Treatment
BRACAnalysis CDx
Shares HRD & BRCA testing, Ovarian cancer, Prostate cancer.
Person
Isabelle Ray-Coquard
Shares HRD & BRCA testing, Ovarian cancer.
Person
Mary-Claire King
Shares HRD & BRCA testing, Ovarian cancer.
Company
Myriad Genetics
Shares HRD & BRCA testing, Ovarian cancer, Prostate cancer.
Treatment
myChoice CDx
Shares HRD & BRCA testing, Ovarian cancer.

cancers

Breast cancer (all types)Ovarian cancer Prostate cancer

technologies

HRD & BRCA testing RAD51 foci assay (functional HRD test)STRIDE DNA break detection (intoDNA)

ProvenanceLast edited 2026-09-17 · Jude Gomila · Header star count stays put on reload; counts grid fills… · diff · file

Sources & links

Official website

Data

Follow this page

Wrong or missing?

Propose a change with a source. Organisations can update their own records. Every suggestion is reviewed, safety-checked and validated before it goes live; nothing is edited directly.

Suggest an editDiscuss start a thread

Out of date?
How review works

Cancers

Ovarian cancer
Breast cancer (all types)
Prostate cancer

Technologies

STRIDE DNA break detection (intoDNA)
HRD & BRCA testing

Not yet reviewedSee the review queue and roster.

Model panel commentary is coming to this page: machine commentary, not clinical review.

Machine-readable versions of intoDNA

JSON record with neighbours
Markdown context for language models
RDF Turtle for this record (its triples, relations and owl:sameAs; the IRI of this record is https://onco.cc/companies/intodna/)
All companies as JSON
RDF N-Triples for the whole corpus
Search index: id, kind, name, TL;DR and route for every record
OpenAPI 3.1 description
API root and meta.json
llms.txt

MCP server: npx -y onco-mcp, tools search, get_entity, list_kind, ask, context, compare. This record is get_entity or context with id intodna.

WebMCP tools registered on this page: onco_search, onco_get_entity.